Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - raw data: Difference between revisions

From GxPlex

Jump to: navigation, search
Migrate to Template:ReferenceData for PageForms (GxPlexBot)
m 1 revision imported
 
(No difference)

Latest revision as of 13:50, 16 July 2026



Document information
Reference WHO WHO - Guidelines for GCP for trials on

pharmaceutical products* 1995

Validity area WHO
Scope(s) HM
Document name WHO - Guidelines for GCP for trials on

pharmaceutical products*

Version / Revision 1995
Status Current
Document type International guideline
Language(s) EN
Description World Health Organization

WHO Technical Report Series, No. 850, 1995, Annex 3 Guidelines for good clinical practice (GCP) for trials on pharmaceutical products*

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 4 — Unit 4.2.1
Scope HM
Document part Glossary - raw data
Language EN
Original entry by Florian Adragna
Contributors
Tags Source documents, Definition, Laboratory

Content

raw data All records or certified copies of original observations, clinical findings or other activities in a clinical trial necessary for the reconstruction and evaluation of the trial. Such material includes laboratory notes, memoranda, calculations and documents, as well as all records of data from automated instruments or exact, verified copies in the form of photocopies, microfiches etc. Raw data can also include photographic negatives, microfilm or magnetic media (e.g. computer diskettes).